LiveActive security incident?Get immediate response
CVE Record

CVE-2023-38955: ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to obtain sensitive information about all mana...

ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to obtain sensitive information about all managed devices, including their IP addresses and device names.

UnknownCVSS not scoredNot KEV-listedUpdated
Discuss exposureBack to CVEs
Glexia's TakeAutomated analysismoderate

Security readout for executives and security teams

Plain-English summary

CVE-2023-38955 is an unauthenticated information disclosure issue in ZKTeco BioAccess IVS v3.3.1. An attacker could obtain sensitive details about all managed devices, including IP addresses and device names. This can expose physical-security infrastructure mapping data, even if the sources do not show direct control of devices.

Executive priority

Prioritize inventory and exposure reduction. This is not evidenced as actively exploited, but it can reveal security-device topology and support later intrusion planning if reachable by unauthorized users.

Technical view

The provided CVE record describes BioAccess IVS v3.3.1 exposing managed-device inventory information without authentication. The disclosed data includes device IP addresses and names. No CVSS score, CWE, CPE, patch, or vendor mitigation details are included in the provided bundle.

Likely exposure

Exposure is most likely for organizations running ZKTeco BioAccess IVS v3.3.1, especially where the application is reachable from untrusted networks. The source bundle does not identify other affected versions or products.

Exploitation context

The source bundle does not indicate CISA KEV listing or active exploitation. The issue is still meaningful because unauthenticated disclosure can aid reconnaissance against access-control and physical-security environments.

Researcher notes

Evidence is limited. The CVE description and Claroty reference support unauthenticated disclosure of managed-device IP addresses and names in BioAccess IVS v3.3.1. The bundle does not provide CVSS, CWE, exploit status, proof details, or official fix information.

Mitigation direction

  • Identify any BioAccess IVS v3.3.1 deployments.
  • Check ZKTeco or Claroty guidance for patched versions or official mitigations.
  • Restrict BioAccess IVS access to trusted administrative networks.
  • Remove public or broadly reachable access where operationally possible.
  • Treat exposed device names and IP addresses as sensitive infrastructure data.

Validation and detection

  • Confirm whether deployed BioAccess IVS versions match v3.3.1.
  • Review network exposure for BioAccess IVS management interfaces.
  • Verify unauthenticated users cannot view managed-device inventory data.
  • Check whether device names or IP addresses were exposed in logs or monitoring.
  • Monitor CVE, vendor, and Claroty references for updated remediation details.
Prepared
Confidence
medium
Sources
3

Public sources used

Generated from the cited source records. This long-tail analysis has not been individually reviewed by a named human.

Potential ATT&CK relevance

Conservative CVE-to-ATT&CK context

These mappings and lookup hints may be relevant to the vulnerability behavior, CWE, affected product, or exposure path. Glexia-inferred context is not an official MITRE, ATT&CK, CWE, or CVE Program mapping.

ATT&CK lookup starting points

Use these exact CWE pages and searches to review the Glexia ATT&CK library from this CVE's weakness and description context.

cve · low confidence lookup

CVE-2023-38955 mapping review

Open the CVE-to-ATT&CK bridge for reviewed, inferred, or future official mappings tied to this CVE.

Open ATT&CK lookup
Vulnerability profileCVE Program record
Severity
Unknown
CVSS
Not scored
Known Exploited
No
Published
Official CVE source material

CNA and ADP enrichment extracted from CVE v5

These fields come from the CVE record and ADP containers, not from Glexia's Take. They preserve time-varying source decisions such as CISA SSVC, KEV status, CVSS metrics, and provider references.

0CVSS vectors
3Timeline events
2ADP providers
2Source links

SSVC decision data

CISA-ADPCISA Coordinator
Timestamp
Version
2.0.3
Exploitation: noneAutomatable: yesTechnical Impact: partial

Vulnerability timeline

Timeline events are normalized from CVE metadata, CNA source timelines, ADP timelines, and KEV metadata when present.

  1. CVE reservedCVE Program

    The CVE ID was reserved by the assigning CNA.

  2. CVE publishedCVE Program

    The CVE record was published.

  3. CVE updatedCVE Program

    The CVE record metadata indicates this as the latest update time.

ADP provider summaries

CVECVE Program Container
CISA-ADPCISA ADP Vulnrichment
other:ssvc

Source materials

Affected products

Products and packages named in the record

VendorProductVersion / packageStatus
n/an/an/aListed
Weakness

CWE details

No CWE listed

CWE links open Glexia weakness intelligence pages with official CWE context, developer remediation guidance, and related CVE mappings.